Bruna Dalmasso

1.2k total citations
22 papers, 350 citations indexed

About

Bruna Dalmasso is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Bruna Dalmasso has authored 22 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Bruna Dalmasso's work include Melanoma and MAPK Pathways (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and DNA Repair Mechanisms (4 papers). Bruna Dalmasso is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), Cutaneous Melanoma Detection and Management (6 papers) and DNA Repair Mechanisms (4 papers). Bruna Dalmasso collaborates with scholars based in Italy, Belgium and Spain. Bruna Dalmasso's co-authors include Annouschka Laenen, Cindy Kenis, Sigrid Hatse, Hans Wildiers, Paola Ghiorzo, Barbara Brouwers, Patrick Schöffski, Patrick Neven, Ann Smeets and William Bruno and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Bruna Dalmasso

20 papers receiving 349 citations

Peers

Bruna Dalmasso
Bruna Dalmasso
Citations per year, relative to Bruna Dalmasso Bruna Dalmasso (= 1×) peers Jizhun Zhang

Countries citing papers authored by Bruna Dalmasso

Since Specialization
Citations

This map shows the geographic impact of Bruna Dalmasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruna Dalmasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruna Dalmasso more than expected).

Fields of papers citing papers by Bruna Dalmasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruna Dalmasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruna Dalmasso. The network helps show where Bruna Dalmasso may publish in the future.

Co-authorship network of co-authors of Bruna Dalmasso

This figure shows the co-authorship network connecting the top 25 collaborators of Bruna Dalmasso. A scholar is included among the top collaborators of Bruna Dalmasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruna Dalmasso. Bruna Dalmasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Croce, Michela, Bruna Dalmasso, Virginia Andreotti, et al.. (2025). Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma. International Journal of Molecular Sciences. 26(15). 7420–7420.
3.
Dalmasso, Bruna & Paola Ghiorzo. (2023). Long Non-Coding RNAs and Metabolic Rewiring in Pancreatic Cancer. Cancers. 15(13). 3486–3486. 6 indexed citations
4.
Pastorino, Lorenza, Bruna Dalmasso, Irene Vanni, et al.. (2022). Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma. International Journal of Molecular Sciences. 23(24). 16027–16027. 4 indexed citations
5.
Wu, Qi, Barbara Brouwers, Bruna Dalmasso, et al.. (2022). Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study. Translational Oncology. 25. 101527–101527. 5 indexed citations
6.
Dalmasso, Bruna, Alberto Puccini, Fabio Catalano, et al.. (2022). Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients. International Journal of Molecular Sciences. 23(9). 4709–4709. 15 indexed citations
7.
Spagnolo, Francesco, Bruna Dalmasso, Enrica T. Tanda, et al.. (2021). Efficacy of BRAF and MEK Inhibition in Patients with BRAF-Mutant Advanced Melanoma and Germline CDKN2A Pathogenic Variants. Cancers. 13(10). 2440–2440. 6 indexed citations
8.
Vanni, Irene, Enrica T. Tanda, Bruna Dalmasso, et al.. (2020). Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications. Frontiers in Molecular Biosciences. 7. 172–172. 25 indexed citations
9.
Ciccarese, Giulia, Bruna Dalmasso, William Bruno, et al.. (2020). Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients. Journal of Translational Medicine. 18(1). 78–78. 22 indexed citations
10.
Spagnolo, Francesco, Bruna Dalmasso, Hildur Helgadóttir, et al.. (2020). 1130P BRAF and MEK inhibition in CDKN2A germline carriers and BRAF mutant melanoma. Annals of Oncology. 31. S759–S759. 1 indexed citations
11.
Dalmasso, Bruna & Paola Ghiorzo. (2020). Evolution of approaches to identify melanoma missing heritability. Expert Review of Molecular Diagnostics. 20(5). 523–531. 8 indexed citations
12.
Wildiers, Hans, Cindy Kenis, Bruna Dalmasso, et al.. (2020). Computerized scoring tool for identification and quantification of different immune cell populations in breast tumor regions. European Journal of Cancer. 138. S71–S71.
13.
Floris, Giuseppe, Cindy Kenis, Bruna Dalmasso, et al.. (2020). Age‐related remodelling of the blood immunological portrait and the local tumor immune response in patients with luminal breast cancer. Clinical & Translational Immunology. 9(10). 30 indexed citations
14.
Dalmasso, Bruna, Sigrid Hatse, Barbara Brouwers, et al.. (2018). Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy. BMC Cancer. 18(1). 1014–1014. 18 indexed citations
15.
Dalmasso, Bruna, Lorenza Pastorino, Giulia Ciccarese, et al.. (2018). CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients. Journal of the American Academy of Dermatology. 80(5). 1263–1271. 13 indexed citations
16.
Bruno, William, Bruna Dalmasso, Virginia Andreotti, et al.. (2017). Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations. Oncotarget. 9(5). 5691–5702. 11 indexed citations
17.
Brouwers, Barbara, Sigrid Hatse, Lissandra Dal Lago, et al.. (2016). The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters. Oncotarget. 7(21). 29977–29988. 43 indexed citations
18.
Bruno, William, Virginia Andreotti, Lorenza Pastorino, et al.. (2016). Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry. Oncotarget. 8(5). 8069–8082. 29 indexed citations
19.
Hatse, Sigrid, Barbara Brouwers, Bruna Dalmasso, et al.. (2014). Circulating MicroRNAs as Easy-to-Measure Aging Biomarkers in Older Breast Cancer Patients: Correlation with Chronological Age but Not with Fitness/Frailty Status. PLoS ONE. 9(10). e110644–e110644. 57 indexed citations
20.
Fornaro, Michele, Matteo Martino, Bruna Dalmasso, et al.. (2011). An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects. Annals of General Psychiatry. 10(1). 23–23. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026